Distinguished in Psoriatic Arthritis
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Sarah L. Ringold's experience treating your condition:
About Dr. Sarah L. Ringold

Sarah Ringold is a Pediatric Rheumatologist and a Pediatrics expert in Seattle, Washington. Ringold has been practicing medicine for over 22 years and is rated as a Distinguished expert by MediFind in the treatment of Psoriatic Arthritis. She is also highly rated in 5 other conditions, according to our data. Her top areas of expertise are Juvenile Idiopathic Arthritis (JIA), Psoriatic Arthritis, Arthritis, and Adult Still's Disease. She is licensed to treat patients in Washington. Ringold is currently accepting new patients.

Her clinical research consists of co-authoring 72 peer reviewed articles and participating in 3 clinical trials in the past 15 years. In particular, she has co-authored 46 articles and participated in 2 clinical trials in the study of Psoriatic Arthritis.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Sarah L. Ringold it is best to call her office and ask if your insurance is accepted.

Call to see if your plan is accepted.
4800 Sand Point Way Ne, Ma.7.110, Seattle, WA 98105
Background & Education
Graduate Institution
Harvard Medical School, 2001
Pediatric Rheumatology
Pediatric Rheumatology in WA
Hospital Affiliations
Seattle Childrens Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
An Open Label, Multi-Center, Phase 3 Efficacy Study of Sub-Q Abatacept in Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)
Start Time Optimization of Biologics in Polyarticular JIA
View 1 Less Clinical Trial -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors